Reaction
Mastoiditis reporting signals
As of the last recalculation, Mastoiditis appears in 960 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 102.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 48 | 102.7 | 103.2 |
| Botulinum Toxin Type A | 43 | 78.6 | 78.8 |
| Acetaminophen And Codeine | 26 | 47.5 | 47.6 |
| Cyclobenzaprine | 50 | 22.9 | 22.9 |
| Lidocaine Hydrochloride | 52 | 19.7 | 19.7 |
| Cyclobenzaprine Hydrochloride | 7 | 17.0 | 17.0 |
| Sirolimus | 10 | 16.3 | 16.3 |
| Propranolol Hydrochloride | 48 | 15.1 | 15.2 |
| Erenumab-Aooe | 35 | 14.3 | 14.3 |
| Diclofenac Potassium, Film Coated | 4 | 10.3 | 10.3 |
| Diclofenac Potassium Tablets | 4 | 10.3 | 10.3 |
| Diclofenac Potassium | 5 | 10.1 | 10.1 |
| Morphine Sulfate | 50 | 9.4 | 9.4 |
| Daratumumab | 16 | 8.8 | 8.8 |
| Pomalidomide | 21 | 4.5 | 4.5 |
| Dornase Alfa | 4 | 4.4 | 4.4 |